Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 20 12:23PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-6.38 Insider Own18.14% Shs Outstand47.35M Perf Week2.71%
Market Cap3.69B Forward P/E- EPS next Y-0.14 Insider Trans-0.66% Shs Float38.88M Perf Month14.42%
Income-296.38M PEG- EPS next Q-1.30 Inst Own80.74% Short Float19.83% Perf Quarter-4.25%
Sales251.02M P/S14.70 EPS this Y8.35% Inst Trans16.46% Short Ratio10.53 Perf Half Y30.11%
Book/sh3.03 P/B25.60 EPS next Y97.20% ROA-63.40% Short Interest7.71M Perf Year1.07%
Cash/sh6.98 P/C11.13 EPS next 5Y- ROE-231.68% 52W Range55.02 - 98.40 Perf YTD-2.39%
Dividend Est.- P/FCF- EPS past 5Y-35.53% ROI-89.36% 52W High-21.05% Beta1.26
Dividend TTM- Quick Ratio3.09 Sales past 5Y88.16% Gross Margin87.01% 52W Low41.20% ATR (14)2.97
Dividend Ex-Date- Current Ratio3.20 EPS Y/Y TTM-67.92% Oper. Margin-97.62% RSI (14)57.82 Volatility3.77% 4.11%
Employees545 Debt/Eq1.32 Sales Y/Y TTM73.58% Profit Margin-118.07% Recom1.19 Target Price124.60
Option/ShortYes / Yes LT Debt/Eq1.30 EPS Q/Q-459.46% Payout- Rel Volume0.45 Prev Close76.54
Sales Surprise2.33% EPS Surprise-19.55% Sales Q/Q-20.70% EarningsMay 06 BMO Avg Volume732.40K Price77.69
SMA204.46% SMA505.38% SMA2003.88% Trades Volume156,898 Change1.50%
Date Action Analyst Rating Change Price Target Change
Apr-29-24Upgrade Morgan Stanley Equal-Weight → Overweight $90 → $115
Mar-19-24Initiated Robert W. Baird Outperform $108
Feb-06-24Initiated UBS Buy $111
Jan-25-24Initiated RBC Capital Mkts Outperform $126
Dec-13-23Initiated Citigroup Buy $125
Aug-08-23Upgrade BofA Securities Underperform → Neutral $59 → $81
Jan-05-23Initiated Piper Sandler Neutral $75
Nov-01-22Initiated Loop Capital Buy $95
Sep-07-22Resumed Mizuho Buy $49 → $76
Aug-10-21Downgrade Morgan Stanley Overweight → Equal-Weight $105 → $34
May-18-24 06:47AM
May-13-24 07:57PM
May-11-24 10:00AM
May-08-24 07:00AM
11:26AM Loading…
May-07-24 11:26AM
May-06-24 10:55PM
May-03-24 08:30AM
May-01-24 07:00AM
Apr-30-24 03:20PM
04:01PM Loading…
Apr-29-24 04:01PM
Apr-22-24 09:16AM
Apr-15-24 07:00AM
Apr-10-24 07:00AM
Apr-02-24 10:24AM
Apr-01-24 07:00AM
Mar-27-24 07:44AM
Mar-26-24 11:24AM
Mar-25-24 07:00AM
Mar-23-24 06:45AM
10:00AM Loading…
Mar-22-24 10:00AM
Mar-21-24 11:30AM
Mar-20-24 12:12PM
Mar-19-24 07:00AM
Mar-13-24 03:32PM
Mar-05-24 07:00AM
Feb-27-24 07:00AM
Feb-26-24 03:04PM
Feb-21-24 10:39AM
Feb-20-24 10:39PM
Feb-13-24 10:00AM
Feb-08-24 07:45AM
Jan-23-24 11:01AM
Jan-05-24 10:21AM
Jan-04-24 07:00AM
Jan-03-24 05:20AM
Jan-02-24 08:45AM
Jan-01-24 06:50AM
Dec-11-23 07:00AM
Dec-10-23 06:56AM
Dec-07-23 07:00AM
Nov-28-23 06:51PM
Nov-27-23 09:50AM
Nov-22-23 07:00AM
Nov-21-23 07:00AM
Nov-11-23 06:50AM
Nov-09-23 10:23AM
Nov-07-23 11:02AM
Nov-06-23 08:09AM
Nov-02-23 07:00AM
Oct-31-23 07:00AM
Oct-27-23 05:00AM
Oct-25-23 08:45AM
Oct-24-23 07:00AM
Oct-23-23 05:30AM
Oct-11-23 07:00AM
Oct-10-23 07:00AM
Oct-03-23 05:30AM
Oct-02-23 07:00AM
Sep-21-23 07:00AM
Sep-15-23 10:23AM
Sep-12-23 06:00AM
Sep-07-23 07:03AM
Sep-05-23 07:00AM
Aug-30-23 08:00AM
Aug-24-23 10:07AM
Aug-19-23 05:52AM
Aug-10-23 05:50AM
Aug-09-23 08:37AM
Aug-08-23 12:21PM
Aug-07-23 07:00AM
Aug-05-23 06:55AM
Aug-03-23 09:45AM
Aug-02-23 10:23AM
Jul-20-23 08:08AM
Jul-13-23 05:50AM
Jul-12-23 07:00AM
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jacobson Mark L.Chief Operating OfficerApr 01 '24Option Exercise1.3024,66232,06124,662Apr 01 06:46 PM
Jacobson Mark L.Chief Operating OfficerApr 01 '24Sale77.2424,6621,904,9420Apr 01 06:46 PM
JEFFS ROGERDirectorMar 15 '24Option Exercise29.912,34770,199123,103Mar 15 08:05 PM
JEFFS ROGERDirectorMar 15 '24Sale71.612,347168,062120,756Mar 15 08:05 PM
JEFFS ROGERDirectorMar 14 '24Option Exercise24.0129,976719,787137,732Mar 15 08:05 PM
JEFFS ROGERDirectorMar 14 '24Sale69.7029,9762,089,387120,756Mar 15 08:05 PM
Coleman MarkDirectorSep 15 '23Option Exercise3.6711,01640,42936,113Sep 15 06:30 PM
Coleman MarkDirectorSep 15 '23Sale75.1818,5721,396,189403,856Sep 15 06:30 PM
Coleman MarkDirectorSep 15 '23Sale75.1911,016828,24125,097Sep 15 06:30 PM